Stevens-Johnson Scars? California Lawyers Fight Back
If SJS/TEN left you with lasting scars or complications, California law may offer paths to compensation against drug manufacturers (primarily for failure to warn or manufacturing defects), prescribers, and pharmacies. Deadlines can be short—especially for claims tied to medical care or government entities—so speak with a California attorney promptly. Contact us for a free consultation.
What is SJS/TEN and why scarring matters
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe reactions—often to medications—that damage the skin and mucous membranes. Survivors frequently face permanent scarring, pigmentation changes, contractures, ocular issues, chronic pain, and psychological trauma. These life-altering injuries can affect work, daily activities, and quality of life, forming the basis for damages in a civil claim.
Practical tips
- Document early: Take dated photos of affected areas and keep a symptom diary.
- Save evidence: Store medication bottles, packaging, and receipts in a safe place.
- Centralize records: Request complete medical, pharmacy, and employment records to streamline your claim.
Common legal theories in California SJS/TEN cases
- Product liability against drug manufacturers. California generally recognizes product liability theories, but for prescription drugs the law is distinctive: strict-liability design-defect claims are generally unavailable (Brown v. Superior Court (Abbott Laboratories)), while failure-to-warn and manufacturing-defect theories remain (Carlin v. Superior Court; CACI 1201; CACI 1205). In prescription-drug cases, the duty to warn typically runs to the prescribing physician under the learned intermediary doctrine (Carlin). In limited circumstances, a brand-name manufacturer may face negligence-based warning liability even if the patient took a generic equivalent (T.H. v. Novartis Pharmaceuticals Corp.).
- Medical negligence. Claims can arise from delayed recognition or management of SJS/TEN—for example, not discontinuing a reasonably suspected causative drug or delaying referral to higher-level care. Liability turns on whether the provider met the applicable professional standard of care (CACI 501).
- Pharmacy errors. Pharmacies must accurately dispense medications and comply with consultation requirements (16 CCR §1707.2). California courts generally do not impose on pharmacists a broad duty to warn patients about drug risks beyond the prescription and label absent a specific undertaking, but pharmacists may be liable for misfills or other dispensing errors (Huggins v. Longs Drug Stores).
- Related claims. Depending on the facts, claims may include negligent infliction of emotional distress and loss of consortium.
Proving liability and damages
Strong cases combine medical and factual evidence:
- Medical records: Hospitalizations, burn unit care, dermatology/ophthalmology notes, biopsy and lab results, and medication administration records.
- Drug exposure timeline: Prescriptions, pharmacy fill logs, over-the-counter use, and any prior reactions.
- Causation analysis: Expert dermatology/pharmacology opinions linking the drug or conduct to SJS/TEN and resultant scarring. For failure-to-warn, evidence on known or knowable risks is key (Anderson v. Owens-Corning).
- Extent of harm: Photographs over time, functional assessments, pain and suffering narratives, and mental health evaluations.
- Economic losses: Past/future medical care (scar revision, laser therapy, ocular procedures), rehabilitation, assistive devices, lost income, and diminished earning capacity.
Compensation you may pursue
Recoverable damages can include medical expenses, rehabilitation costs, lost wages and earning capacity, pain and suffering, disfigurement, and loss of enjoyment of life (CACI 3905A). In appropriate cases, punitive damages may be available for oppressive, fraudulent, or malicious conduct (Civ. Code §3294). Families may seek wrongful death damages when SJS/TEN is fatal (CCP §377.60).
Deadlines to file in California
- General personal injury/products claims: Typically two years from injury (CCP §335.1), subject to the discovery rule (Jolly v. Eli Lilly & Co.).
- Medical malpractice: The earlier of one year after discovery or three years after the date of injury, with statutory exceptions (CCP §340.5).
- Claims involving government entities: An administrative claim must usually be presented within six months of accrual, with strict timelines to sue after rejection (Gov. Code §911.2; §945.6).
Because exceptions and tolling rules may apply (for example, for minors), consult counsel promptly to protect your rights.
Checklist: What to do if you suspect SJS/TEN from a medication
- Seek immediate medical care and follow specialist guidance.
- Preserve the medication, packaging, and receipts.
- Keep a written timeline of symptoms, providers, and treatments.
- Photograph injuries regularly as they evolve.
- Avoid discussing fault with insurers before consulting counsel.
- Contact a California attorney experienced in drug-injury and medical-negligence cases. We can help.
How our California team helps
We investigate drug histories and warnings, obtain and analyze medical records, consult qualified experts, and build a comprehensive damages presentation centered on scarring and long-term complications. We handle negotiations and litigation while you focus on healing. Consultations are confidential, and there are no upfront fees in contingency matters—we are only paid if we recover compensation for you.
Frequently asked questions
Do I need the exact drug identified?
Not always. A careful causation analysis can evaluate suspect exposures and rule in or out potential culprits.
What if I signed a consent form?
Consent does not excuse negligent care or inadequate warnings.
Can multiple parties be liable?
Yes. Depending on the facts, manufacturers, prescribers, and pharmacies may share responsibility.
Are class actions common?
Many SJS/TEN claims proceed individually due to highly individualized causation and damages.
Next steps
If you or a loved one has SJS/TEN scarring, contact a California lawyer as soon as possible to evaluate your options and preserve your claims. A focused, evidence-driven approach can make the difference in securing resources for ongoing care and recovery. Speak with our team or schedule a free consultation today.
Key legal citations
- Brown v. Superior Court (Abbott Laboratories), 44 Cal.3d 1049 (Cal. 1988)
- Carlin v. Superior Court, 13 Cal.4th 1104 (Cal. 1996)
- Anderson v. Owens-Corning Fiberglas Corp., 53 Cal.3d 987 (Cal. 1991)
- CACI 1201 (Manufacturing Defect); CACI 1205 (Failure to Warn); CACI 501 (Medical Standard of Care); CACI 3905A (Noneconomic Damages)
- CCP §335.1; CCP §340.5; Gov. Code §911.2; §945.6; Civ. Code §3294; CCP §377.60
- Jolly v. Eli Lilly & Co., 44 Cal.3d 1103 (Cal. 1988)
- 16 CCR §1707.2 (Pharmacist Consultation)
- T.H. v. Novartis Pharmaceuticals Corp., 4 Cal.5th 145 (Cal. 2017)
Disclaimer (California): This post is for general information only and is not legal or medical advice. Reading it does not create an attorney–client relationship. Laws and deadlines change and depend on your facts. Consult a qualified California attorney about your situation.